RITM, DOH, Philippines Report issue

Government

Organization Overview

First Clinical Trial
2003
NCT00229775
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2003

Timeline

NOW
  • Now

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 5